Yes spot on. The SP rose with no announcements into the high $4s so that was obviously due to holders getting exciting and cheering others to join in. Then a hint of negative news in the briefing and there was more risk than gain so the smart ones sold out. ie; gain 50c versus lose $3
aGVHD was always expected to be approved. It is actively used in Japan already and there is no alternate treatment. If aGVHD was voted down then this whole company would be in the sheets.
Not analyst forecasts for sales/profit for aGVHD is relatively low compared with covid ards (highest) and CHF (better than aGVHD).
But at least this news sets a new low. My new trading range until covid ards / CHF results is $5 - $6.
Only covid ards will send us to the moon, otherwise with CHF we still looking at $10 if approved (that is immediate price).
MSB Trading 2020 - a new dawn, page-416
-
- There are more pages in this discussion • 12,655 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |